| Financial Year |
March 31 2023 |
| Monetary Funds |
5,693,019,477.87 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,500,000.00 |
| Accounts Receivable |
302,190,764.81 |
| Advances to Suppliers |
90,115,486.60 |
| Other Receivables |
632,136,165.61 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
124,178,517.25 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
78,160,651.65 |
| Total Current Assets |
6,938,055,022.90 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,316,748,288.99 |
| Investment Properties |
-- |
| Fixed Assetes |
7,300,443,670.10 |
| Under-construction Projects |
5,028,415,856.12 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
8,867,996,440.03 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
144,711,578.19 |
| Deferred Income Tax Assets |
84,250,391.85 |
| Other Non-Current Assets |
67,909,382.72 |
| Sub-Total of Non-Current Assets |
23,329,629,364.08 |
| Total Assets |
30,267,684,386.98 |
| Short-Term Loans |
30,025,208.33 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,293,532,471.74 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
128,976,793.00 |
| Taxes Payable |
218,890,921.50 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
716,344,699.30 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
409,793,209.21 |
| Other Current Liabilities |
89,493,989.80 |
| Sub-Total of Current Liabilities |
3,563,224,391.79 |
| Long-term Loans |
7,850,820,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
2,945,422,599.42 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,104,071,898.99 |
| Deferred Income Tax Liabilities |
51,907,385.12 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
12,248,112,893.99 |
| Total Liabilities |
15,811,337,285.78 |
| Paid-In Capital(Or Share Stock) |
1,439,997,926.00 |
| Capital Surplus |
3,082,635,030.40 |
| Surplus Reserve |
950,764,399.94 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,005,635,872.82 |
| Minority Stockholder's Interest |
3,440,519,990.58 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,015,827,110.62 |
| Owner's Equity（Stockholder's Equity） |
14,456,347,101.20 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
30,267,684,386.98 |
